Health care and life sciences companies face a variety of issues in 2014, including further difficulties with the Affordable Care Act (ACA) rollout because of legal and logistical challenges, the potential dampening of dealmaking due to ACA and...
By: Skadden, Arps, Slate, Meagher & Flom LLP
By: Skadden, Arps, Slate, Meagher & Flom LLP